CARGO Therapeutics Inc(NASDAQ:CRGX) 
CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor T-cell therapies for cancer patients.
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-02-20
P
O 3.90
H 3.95
L 3.68
C 3.69
V 498,854
10EMA 3.69
20EMA 3.69
60EMA 3.69
120EMA 3.69
250EMA 3.69